Arecor (LON:AREC) Presenting at the Proactive One2One Virtual Forum – October 2021



Sarah Howell (CEO) & Susan Lowther (CFO) Presenting at the Proactive One2One Virtual Forum – October 2021

Arecor is a globally focused biopharmaceutical company that is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products.

By applying our innovative proprietary formulation technology platform, Arestat™, we are developing a portfolio of proprietary products in diabetes and other indications and working with leading pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies.

source

English English German German